Advarra is a technology and services company focused on clinical trials. It operates as the leading independent Institutional Review Board (IRB) and provides platforms, data analytics, and operational expertise to make research more efficient. The company has more than four decades of leadership in ethical review and has served more than 72,000 research sites.
Its technology portfolio includes AI-powered data and analytics. The Braid platform, for example, applies artificial intelligence to provide operational intelligence for study design and decision-making in clinical research. Other key products include clinical trial management systems (OnCore, Clinical Conductor), a proprietary IRB management platform (CIRBI), and a regulatory document management solution (eReg).
Advarra's work spans multiple therapeutic areas, including oncology, neurodegenerative and CNS diseases, rare diseases, cell and gene therapy, pediatrics, infectious diseases, and metabolic diseases. It serves pharmaceutical and biotechnology companies as well as contract research organizations.
